Smaller portions, more protein: how GLP-1s are quietly changing chain restaurants
In the longer term, "once this obesity benefit is established, we believe it will be practically and politically difficult to roll back as we look toward 2028 and beyond," J.P.Morgan analyst Chris Schott said, according to Reuters
Current research explores roles in diabetes, heart health, and neurodegeneration
About 1 in 3 people in the United States will get shingles, resulting in about 1 million cases a year
Dexmedetomidine, an 2-adrenergic receptor agonist, exerts a short-acting calming effect while modulating intestinal microbiota and extrenteral organs via the subphrenovagus nerve